Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
4
%Wording
Conditional
How definitive the wording is.Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPNet Sales560,728¥ millionYear on year +4.0%Progress 97.5%
Operating profit73,702¥ millionYear on year +2.8%Progress 97.0%
Ordinary income82,753¥ millionYear on year +14.9%Progress 110.3%
Net income attributable to owners of the parent60,499¥ millionYear on year +12.5%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥209.39
Operating Margin13.1%
Financial position at period-end
Total assets737,978¥ million
of which net assets 565,166 ¥ millionEquity ratio 76.6%vs. prior year-end +2.5pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+54,679
Investment-15,907
Financials-25,504
Net change+13,268
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥160,839 million
Segment revenueMeasurement Equipment ¥364,908 million (YoY +4.9%), Medical Equipment ¥73,794 million (YoY +1.7%), Industrial Equipment ¥71,523 million (YoY -1.1%), Aircraft equipment ¥43,371 million (YoY +12.2%)
Segment profitMeasurement Equipment ¥52,578 million (YoY +1.0%), Medical Equipment ¥4,871 million (YoY +14.3%), Industrial Equipment ¥10,595 million (YoY +1.2%), Aircraft equipment ¥8,220 million (YoY +35.5%)
Regional sales¥242,581 million (YoY +3.4%), ¥81,866 million (YoY +4.2%), ¥54,802 million (YoY +10.6%), ¥91,736 million (YoY +0.4%), ¥71,468 million (YoY +10.0%), ¥18,272 million (YoY -8.8%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥575,000 million (YoY +2.5%)
Operating profit¥76,000 million (YoY +3.1%)
Ordinary income¥75,000 million (YoY -9.4%)
Profit attributable to owners of the parent¥55,000 million (YoY -9.1%)
Annual Dividend Forecast¥69 → ¥70（+1.4%）
Payout ratio33.0% (next fiscal year forecast: 36.8%)
Shareholder Return PolicyMaintain a dividend payout ratio of at least 30% and provide ongoing shareholder returns
Factors Behind Changes in Business Performance
Net sales increased in Japan, North America, Europe and other Asian regions, while operating income increased primarily due to higher net sales and other factors.
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidation0 additions and 0 exclusions (no company names)
Material subsequent eventsNo applicable matters.
Impairment lossNone recorded for the fiscal year (impairment loss on the consolidated statement of income is shown as “—”)
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥255 million, Gain on sale of investment securities ¥18 million / Extraordinary loss Impairment loss on investment securities ¥805 million, Loss on Liquidation of Affiliates ¥426 million, Losses on disposal of fixed assets ¥334 million
Depreciation and amortization¥20,381 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End296,070,227 Shares
Treasury Shares at Period-End7,130,002 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥560,728 million (YoY +4.0%) |
| Operating profit | ¥73,702 million (YoY +2.8%) |
| Ordinary income | ¥82,753 million (YoY +14.9%) |
| Profit attributable to owners of the parent | ¥60,499 million (YoY +12.5%) |
| Net income per share | ¥209.39 |
| Operating Margin | 13.1% |
| Equity ratio | End of the current fiscal period 76.6 / End of previous period 74.1 |
| Total assets | ¥737,978 million |
| Net assets | ¥565,166 million |
| Cash flows from operating activities | ¥54,679 million |
| Cash flows from investing activities | ¥-15,907 million |
| Cash flows from financing activities | ¥-25,504 million |
| Cash and cash equivalents at end of period | ¥160,839 million |
| Full-year earnings forecast | Net Sales ¥575,000 million (YoY +2.5%) / Operating profit ¥76,000 million (YoY +3.1%) / Ordinary income ¥75,000 million (YoY -9.4%) / Profit attributable to owners of the parent ¥55,000 million (YoY -9.1%) |
| Annual Dividend Forecast | ¥69 → ¥70（+1.4%） |
| Payout ratio | 33.0% (next fiscal year forecast: 36.8%) |
| Shareholder Return Policy | Maintain a dividend payout ratio of at least 30% and provide ongoing shareholder returns |
| Segment revenue | Measurement Equipment ¥364,908 million (YoY +4.9%), Medical Equipment ¥73,794 million (YoY +1.7%), Industrial Equipment ¥71,523 million (YoY -1.1%), Aircraft equipment ¥43,371 million (YoY +12.2%) |
| Segment profit | Measurement Equipment ¥52,578 million (YoY +1.0%), Medical Equipment ¥4,871 million (YoY +14.3%), Industrial Equipment ¥10,595 million (YoY +1.2%), Aircraft equipment ¥8,220 million (YoY +35.5%) |
| Regional sales | ¥242,581 million (YoY +3.4%), ¥81,866 million (YoY +4.2%), ¥54,802 million (YoY +10.6%), ¥91,736 million (YoY +0.4%), ¥71,468 million (YoY +10.0%), ¥18,272 million (YoY -8.8%) |
| Depreciation and amortization | ¥20,381 million |
| Impairment loss | None recorded for the fiscal year (impairment loss on the consolidated statement of income is shown as “—”) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥255 million, Gain on sale of investment securities ¥18 million / Extraordinary loss Impairment loss on investment securities ¥805 million, Loss on Liquidation of Affiliates ¥426 million, Losses on disposal of fixed assets ¥334 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | 0 additions and 0 exclusions (no company names) |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 296,070,227 Shares |
| Treasury Shares at Period-End | 7,130,002 Shares |
| Factors Behind Changes in Business Performance | Net sales increased in Japan, North America, Europe and other Asian regions, while operating income increased primarily due to higher net sales and other factors. |
Items this document does not state (2)
Revision to Earnings ForecastOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited increases in net sales in Japan, North America, Europe and other Asian regions as the main reason, while the increase in operating income was attributable primarily to higher net sales and other factors. The company also stated that it advanced initiatives including the launch of new products, strengthening its ability to propose solutions, expanding its recurring-revenue business, and leveraging AI and IoT.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.